## MMC: Marsh & McLennan Companies, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -2.1% below STRENGTH zone (4.0-10.0%); PEG 1.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($175.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Marsh & McLennan Companies, Inc. (NYSE:MMC) Given Consensus Rating of "Hold" by Analysts**
- Source: MarketBeat | 20251204T070934 | Neutral | Relevance: 100%
- Marsh & McLennan Companies, Inc. (NYSE:MMC) has received a consensus "Hold" rating from eighteen brokerages, with an average 12-month price target of $224.56. The company recently exceeded Q3 earnings estimates with $1.85 EPS and $6.35 billion in revenue, reflecting an 11.5% year-over-year increase. Despite a recent sale of shares by CEO John Q. Doyle, institutional investors hold a significant portion of the stock.

**2. Guggenheim Capital LLC Has $17.70 Million Stock Holdings in Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251205T210849 | Neutral | Relevance: 100%
- Guggenheim Capital LLC increased its stake in Marsh & McLennan Companies, Inc. by 8.2% to 80,937 shares, now valued at $17.70 million. This comes as CEO John Q. Doyle recently sold a significant portion of his shares, reducing his holdings by nearly 20%. Marsh & McLennan exceeded quarterly earnings and revenue expectations, maintaining a "Hold" consensus analyst rating with a target price of $223.

**3. M&T Bank Corp Sells 7,410 Shares of Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251204T120917 | Neutral | Relevance: 100%
- M&T Bank Corp reduced its stake in Marsh & McLennan Companies by 15.9%, selling 7,410 shares and now holding 39,229 shares valued at approximately $8.58 million. Simultaneously, CEO John Q. Doyle also sold a significant portion of his holdings, indicating a notable insider sell-off. Despite these sales, Marsh & McLennan reported strong quarterly results and maintains a consensus "Hold" rating from analysts.

**4. Marsh & McLennan Stock: Is MMC Underperforming the Financial Sector?**
- Source: MSN | 20251203T225117 | Somewhat-Bearish | Relevance: 100%
- This article analyzes Marsh & McLennan (MMC) stock performance, noting its recent underperformance compared to the broader financial sector and S&P 500. It details key financial metrics such as net income, earnings growth, and dividend trends, while also providing technical analysis on price movements and analyst ratings. The report suggests MMC might be a value play given its robust fundamentals despite recent market struggles.

**5. Westerkirk Capital Inc. Acquires Shares of 8,110 Marsh & McLennan Companies, Inc. $MMC**
- Source: MarketBeat | 20251203T143933 | Somewhat-Bullish | Relevance: 100%
- Westerkirk Capital Inc. acquired a new stake of 8,110 shares of Marsh & McLennan Companies, Inc. (MMC) during the second quarter, valued at approximately $1.77 million. Other hedge funds also increased their positions, bringing institutional ownership to about 87.99%. Marsh & McLennan reported strong quarterly earnings, beating analyst expectations, with revenue up 11.5% year-over-year, and maintains a consensus "Hold" rating from analysts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Citigroup | $201 | $211 | -5% |
| 2025-11-20 | Barclays | $206 | $221 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-11-20 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.28M) |
| Sells | 1 ($3.84M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 7.9% (-3.7%)
- State Street Corpora: 4.4% (+0.4%)
- Capital Internationa: 3.8% (+1.2%)
- Capital World Invest: 3.6% (+0.5%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Long-term trend broken: trading 14.1% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.86 elevated, pricing in significant growth expectations. Forward P/E 17.6x stretched relative to 7% growth. Quality metrics strong (ROE 29%, margin 16%). Balance sheet: $2.3B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.9B |
| Beta | 0.75 |
| 52W Range | $174.18 - $248.00 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.86 |
| Forward P/E | 17.6 |
| Current P/E | 18.9 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.8% to -2.1% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.86x), long-term trend not supportive. MACD histogram positive (0.79), confirming momentum. RSI neutral at 46. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.15% (CS: 36) | Weak |
| RSI_14 | 45.8 | Neutral |
| MACD Histogram | 0.79 | Bullish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 0.966x | Below |
| vs SMA200 | 0.859x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $181.82
- **Stop Loss:** $175.72 (3.4% risk)
- **Target:** $187.92 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 163
- **Position Value:** $29,636.66
- **Portfolio %:** 29.64%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-29 (Est: $1.97)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $1.85 | +4.1% |
| 2025Q2 | $2.66 | $2.72 | +2.1% |
| 2025Q1 | $3.00 | $3.06 | +2.1% |
| 2024Q4 | $1.76 | $1.87 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*